Free Trial
NYSEAMERICAN:PFNX

Pfenex (PFNX) Stock Price, News & Analysis

Pfenex logo
$12.75 0.00 (0.00%)
As of 10/1/2020

About Pfenex Stock (NYSEAMERICAN:PFNX)

Key Stats

Today's Range
$12.75
$12.75
50-Day Range
$12.75
$12.75
52-Week Range
$5.26
$14.00
Volume
N/A
Average Volume
503,865 shs
Market Capitalization
$437.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PFNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfenex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PFNX Stock News Headlines

NKY Medical Holdings Ltd Class A 300109
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

PFNX Stock Analysis - Frequently Asked Questions

Pfenex's stock was trading at $12.75 at the beginning of 2025. Since then, PFNX shares have increased by 0.0% and is now trading at $12.75.

Pfenex Inc. (NYSEAMERICAN:PFNX) announced its quarterly earnings data on Thursday, May, 7th. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.07. The biotechnology company earned $0.68 million during the quarter, compared to analysts' expectations of $3.75 million.

Shares of PFNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pfenex investors own include Inovio Pharmaceuticals (INO), Verastem (VSTM), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Bristol Myers Squibb (BMY), Gilead Sciences (GILD) and Ocular Therapeutix (OCUL).

Company Calendar

Last Earnings
5/07/2020
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:PFNX
Previous Symbol
NYSEMKT:PFNX
CIK
N/A
Fax
N/A
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,297,000
Free Float
N/A
Market Cap
$437.29 million
Optionable
Not Optionable
Beta
N/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSEAMERICAN:PFNX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners